Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK12-IN-E9 is a potent and selective covalent CDK12 inhibitor and non-covalent CDK9 inhibitor while avoiding ABC transporter-mediated efflux. It has a weak binding ability to CDK7/CyclinH complex (IC50> 1 μM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 291,500 |
50 mg | 約6-8 週間 | ¥ 379,000 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | CDK12-IN-E9 is a potent and selective covalent CDK12 inhibitor and non-covalent CDK9 inhibitor while avoiding ABC transporter-mediated efflux. It has a weak binding ability to CDK7/CyclinH complex (IC50> 1 μM). |
ターゲット&IC50 | CDK2-CyclinA:932 nM, CDK7-CyclinH-MNAT1:1210 nM, CDK9-CyclinT1:23.9 nM |
分子量 | 434.53 |
分子式 | C24H30N6O2 |
CAS No. | 2020052-55-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK12-IN-E9 2020052-55-3 Cell Cycle/Checkpoint CDK CDK-12-IN-E9 CDK12INE9 CDK12 IN E9 Inhibitor inhibitor inhibit